Evidence map›Paper›PMID 27829061›Full record

ArticlePloS one2016

RGS10 Negatively Regulates Platelet Activation and Thrombogenesis.

Nicole R Hensch, Zubair A Karim, Kirk M Druey, Malú G Tansey, Fadi T Khasawneh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. A regulatory node involving GαJournal of thrombosis and haemostasis : JTH · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Roles of GRKs in Hemostasis and Thrombosis.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Negative regulators of platelet activation and adhesion.Journal of thrombosis and haemostasis : JTH · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nicole R HenschDepartment of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States of America.
Zubair A KarimDepartment of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States of America.
Kirk M DrueyMolecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH, 10 Center Drive Room 11S244B, Bethesda, Maryland 20892, United States of America.
Malú G TanseyDepartment of Physiology, Emory University School of Medicine, Atlanta, GA 30322, United States of America.
Fadi T KhasawnehDepartment of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States of America.
Western University of Health Sciences · USEmory University · USNational Institute of Allergy and Infectious Diseases · US

Funding

Heterotrimeric G Protein Signaling In Allergic InflammationZIAAI000746 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DRUEY, KIRK M · 2009 to 2025
$4.6M
6 · The paper itself

Abstract

Regulators of G protein signaling (RGS) proteins act as GTPase activating proteins to negatively regulate G protein-coupled receptor (GPCR) signaling. Although several RGS proteins including RGS2, RGS16, RGS10, and RGS18 are expressed in human and mouse platelets, the respective unique function(s) of each have not been fully delineated. RGS10 is a member of the D/R12 subfamily of RGS proteins and is expressed in microglia, macrophages, megakaryocytes, and platelets. We used a genetic approach to examine the role(s) of RGS10 in platelet activation in vitro and hemostasis and thrombosis in vivo. GPCR-induced aggregation, secretion, and integrin activation was much more pronounced in platelets from Rgs10-/- mice relative to wild type (WT). Accordingly, these mice had markedly reduced bleeding times and were more susceptible to vascular injury-associated thrombus formation than control mice. These findings suggest a unique, non-redundant role of RGS10 in modulating the hemostatic and thrombotic functions of platelets in mice. RGS10 thus represents a potential therapeutic target to control platelet activity and/or hypercoagulable states.

Indexed as

Adenosine DiphosphateAnimalsBleeding TimeBlood PlateletsBlotting, WesternFlow CytometryHemostasisMice, KnockoutPlatelet ActivationPlatelet AggregationPlatelet Glycoprotein GPIIb-IIIa ComplexReceptors, G-Protein-CoupledRGS ProteinsSignal TransductionThrombosisAdenosine DiphosphatePlatelet Glycoprotein GPIIb-IIIa ComplexReceptors, G-Protein-CoupledRgs10 protein, mouseRGS Proteins

Identifiers

PMID27829061
PMCPMC5102365
OpenAlexW2554470111

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.